Viewing Study NCT05158894

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-03-11 @ 12:56 AM
Study NCT ID: NCT05158894
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2021-12-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Migraine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Migraine View
None Ubrelvy View
None Ubrogepant View
None Atogepant View
None Qulipta View
None MED-EPI-NEU-0649 View